These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 7508113)
41. [KI-67 PAP stain for histologic grading of brain tumors by squash preparations]. Shibata T; Ostertag CB; Volk B No To Shinkei; 1989 Jan; 41(1):55-60. PubMed ID: 2470401 [TBL] [Abstract][Full Text] [Related]
42. PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes. Galand P; Del Bino G; Morret M; Capel P; Degraef C; Fokan D; Feremans W Leukemia; 1995 Jun; 9(6):1075-84. PubMed ID: 7596173 [TBL] [Abstract][Full Text] [Related]
43. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors. Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245 [TBL] [Abstract][Full Text] [Related]
44. Value of topoisomerase II alpha, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu immunohistochemical expression for the prediction of biologic behavior in adrenocortical neoplasms. Gupta D; Shidham V; Holden J; Layfield L Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):215-21. PubMed ID: 11556748 [TBL] [Abstract][Full Text] [Related]
46. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract. Lee CS Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306 [TBL] [Abstract][Full Text] [Related]
47. Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningiomas. Zimmer C; Gottschalk J; Cervos-Navarro J; Martin H; Beil M; Jautzke G Pathol Res Pract; 1992 Dec; 188(8):951-8. PubMed ID: 1363764 [TBL] [Abstract][Full Text] [Related]
48. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens. Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072 [TBL] [Abstract][Full Text] [Related]
49. Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB. Vargas MP; Vargas HI; Kleiner DE; Merino MJ Am J Surg Pathol; 1997 May; 21(5):556-62. PubMed ID: 9158680 [TBL] [Abstract][Full Text] [Related]
50. [Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in gynecological tumors and their related lesions]. Sawada M; Ueda G; Inoue M; Shimizu H; Ogawa H; Nakazawa A; Fujita M; Tanizawa O; Tsujimoto M Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):181-7. PubMed ID: 1347557 [TBL] [Abstract][Full Text] [Related]
51. [Study of proliferating cell nuclear antigen (PCNA), nucleolar organizer regions (NORs) and mitotic activity in epithelial ovarian tumors]. Yamanaka S; Nagai N; Ohama K Nihon Sanka Fujinka Gakkai Zasshi; 1993 Mar; 45(3):234-40. PubMed ID: 8098347 [TBL] [Abstract][Full Text] [Related]
52. PCNA defined proliferative activity of epithelial tumor cells in adenomas of the colon. Bielicki D; Markiewski M; Wielondek M; Chosia M; Domagała W Pol J Pathol; 1995; 46(3):151-4. PubMed ID: 7496733 [TBL] [Abstract][Full Text] [Related]
53. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling. Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840 [TBL] [Abstract][Full Text] [Related]
54. Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies. Yang WI; Efird JT; Quintanilla-Martinez L; Choi N; Harris NL Hum Pathol; 1996 Jan; 27(1):70-6. PubMed ID: 8543314 [TBL] [Abstract][Full Text] [Related]
55. Immunocytochemical identification of proliferative hepatocytes using monoclonal antibody to proliferating cell nuclear antigen (PCNA/cyclin). Comparison with immunocytochemical staining for DNA polymerase-alpha. Kawakita N; Seki S; Yanai A; Sakaguchi H; Kuroki T; Mizoguchi Y; Kobayashi K; Monna T Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S14-20. PubMed ID: 1374217 [TBL] [Abstract][Full Text] [Related]
56. Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA. Hepburn PJ; Glynne-Jones E; Goddard L; Gee JM; Harper ME Histochem J; 1995 Mar; 27(3):196-203. PubMed ID: 7797424 [TBL] [Abstract][Full Text] [Related]
57. Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Knosp E; Kitz K; Perneczky A Neurosurgery; 1989 Dec; 25(6):927-30. PubMed ID: 2601824 [TBL] [Abstract][Full Text] [Related]
58. Proliferating cell nuclear antigen counts as markers of cell proliferation in head and neck cancer. Lörz M; Meyer-Breiting E; Bettinger R Eur Arch Otorhinolaryngol; 1994; 251(2):91-4. PubMed ID: 7517683 [TBL] [Abstract][Full Text] [Related]
59. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens. Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445 [TBL] [Abstract][Full Text] [Related]
60. Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation. Willett CG; Warland G; Coen J; Shellito PC; Compton CC Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):57-61. PubMed ID: 7721640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]